Latest Ratios: P/E Ratio 23.4x · EV/EBITDA 24.4x · ROE 5.7%. (2016–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.2B | $802M | $801M | $827M | $916M | $1.3B | $634M | $936M | $553M | — | — |
| Enterprise Value | $1.7B | $1.4B | $1.2B | $1.5B | $1.9B | $2.1B | $1.6B | $2.1B | $1.8B | — | — |
| P/E Ratio → | 23.44 | 15.48 | — | 25.59 | 14.51 | 11.48 | — | 18.16 | 12.05 | — | — |
| P/S Ratio | 2.77 | 1.92 | 2.62 | 2.52 | 2.91 | 4.89 | 2.41 | 3.45 | 2.03 | — | — |
| P/B Ratio | 1.29 | 0.85 | 0.90 | 1.12 | 1.30 | 1.56 | 0.81 | 1.12 | 0.74 | — | — |
| P/FCF | 11.82 | 8.19 | 10.71 | 52.41 | — | 21.31 | 12.28 | 14.59 | 10.61 | — | — |
| P/OCF | 11.52 | 7.98 | 9.75 | 30.96 | — | 19.23 | 11.08 | 11.94 | 8.89 | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 3.28 | 4.06 | 4.42 | 5.93 | 7.89 | 6.06 | 7.90 | 6.44 | — | — |
| EV / EBITDA | 24.42 | 19.40 | — | 30.16 | 22.11 | 13.83 | 315.34 | 30.11 | 26.49 | — | — |
| EV / EBIT | 26.13 | 20.75 | — | 35.15 | 23.76 | 14.52 | — | 33.45 | 30.42 | — | — |
| EV / FCF | — | 14.01 | 16.58 | 92.01 | — | 34.37 | 30.82 | 33.39 | 33.60 | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 89.8% | 89.8% | 80.2% | 81.4% | 95.6% | 106.2% | 66.3% | 101.2% | 99.9% | 101.2% | 91.3% |
| Operating Margin | 15.8% | 15.8% | -7.9% | 12.6% | 25.0% | 54.3% | -1.6% | 23.6% | 21.2% | 27.4% | 13.3% |
| Net Profit Margin | 12.5% | 12.5% | -5.2% | 9.9% | 20.1% | 42.6% | -0.7% | 18.9% | 16.8% | 15.3% | 9.3% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 5.7% | 5.7% | -1.9% | 4.5% | 8.2% | 14.0% | -0.2% | 6.5% | 6.1% | 5.9% | 3.3% |
| ROA | 0.5% | 0.5% | -0.2% | 0.3% | 0.8% | 1.5% | -0.0% | 0.6% | 0.6% | 0.5% | 0.3% |
| ROIC | 2.6% | 2.6% | -1.0% | 1.7% | 3.1% | 5.6% | -0.2% | 2.3% | 2.1% | 3.0% | 1.4% |
| ROCE | 2.2% | 2.2% | -1.3% | 2.1% | 3.8% | 7.1% | -0.2% | 3.0% | 2.8% | 4.1% | 1.9% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.11 | 1.11 | 1.13 | 1.25 | 1.70 | 1.29 | 1.50 | 1.59 | 1.72 | 1.71 | 1.56 |
| Debt / EBITDA | 14.71 | 14.71 | — | 19.13 | 14.20 | 7.07 | 232.18 | 18.66 | 19.42 | 15.00 | 25.61 |
| Net Debt / Equity | — | 0.61 | 0.49 | 0.85 | 1.35 | 0.96 | 1.22 | 1.44 | 1.60 | 1.51 | 1.37 |
| Net Debt / EBITDA | 8.06 | 8.06 | — | 12.98 | 11.26 | 5.26 | 189.74 | 16.95 | 18.13 | 13.21 | 22.46 |
| Debt / FCF | — | 5.83 | 5.87 | 39.61 | — | 13.06 | 18.55 | 18.80 | 22.99 | 17.59 | 14.45 |
| Interest Coverage | 0.28 | 0.28 | -0.09 | 0.19 | 1.09 | 3.37 | -0.06 | 0.64 | 0.64 | 1.21 | 0.72 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.43 | 0.43 | 0.25 | 0.19 | 0.21 | 0.27 | 0.27 | 0.31 | 0.29 | 0.30 | 0.35 |
| Quick Ratio | 0.43 | 0.43 | 0.25 | 0.19 | 0.21 | 0.27 | 0.27 | 0.31 | 0.29 | 0.30 | 0.35 |
| Cash Ratio | 0.08 | 0.08 | 0.07 | 0.04 | 0.04 | 0.05 | 0.04 | 0.02 | 0.01 | 0.02 | 0.02 |
| Asset Turnover | — | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.9% | 1.4% | 1.6% | 1.5% | 1.3% | — | — | — | 7.2% | — | — |
| Payout Ratio | 21.8% | 21.8% | — | 37.1% | 19.3% | — | — | — | 87.3% | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 4.3% | 6.5% | — | 3.9% | 6.9% | 8.7% | — | 5.5% | 8.3% | — | — |
| FCF Yield | 8.5% | 12.2% | 9.3% | 1.9% | — | 4.7% | 8.1% | 6.9% | 9.4% | — | — |
| Buyback Yield | 1.7% | 2.5% | 0.9% | 0.6% | 7.9% | 3.7% | 11.1% | 3.2% | 3.2% | — | — |
| Total Shareholder Yield | 2.7% | 3.9% | 2.5% | 2.1% | 9.2% | 3.7% | 11.1% | 3.2% | 10.5% | — | — |
| Shares Outstanding | — | $41M | $36M | $34M | $34M | $38M | $42M | $43M | $42M | $35M | $35M |
Includes 30+ ratios · 10 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying AMTB stock.
Amerant Bancorp Inc.'s current P/E ratio is 23.4x. The historical average is 16.2x. This places it at the 83th percentile of its historical range.
Amerant Bancorp Inc.'s current EV/EBITDA is 24.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 23.7x.
Amerant Bancorp Inc.'s return on equity (ROE) is 5.7%. The historical average is 5.2%.
Based on historical data, Amerant Bancorp Inc. is trading at a P/E of 23.4x. This is at the 83th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Amerant Bancorp Inc.'s current dividend yield is 0.94% with a payout ratio of 21.8%.
Amerant Bancorp Inc. has 89.8% gross margin and 15.8% operating margin. Operating margin between 10-20% is typical for established companies.
Amerant Bancorp Inc.'s Debt/EBITDA ratio is 14.7x, indicating high leverage. A ratio above 4x may signal elevated financial risk.
Key Metrics
Top Statement Risk
Sub-1% NIM capping franchise returns
Metrics are mathematically derived from official filings.
Book Multiple Prices a Recovery Not Delivered
At a P/B of 1.32 and roughly 1.41x tangible book ($30.06 price against $21.32 TBV per share), Amerant trades above peers like OCFC (0.57x) and SFNC (0.92x) despite a trailing ROE near 2.9%, per current valuation data, implying the market prices an earnings normalization that has not yet materialized.
The gap between the 23.86x trailing P/E and 13.69x forward P/E signals the market expects a substantial earnings step-up, plausibly from the $48.3 million reserve release in 2026Q2 and the efficiency ratio's return to 63.5% after distorted quarters, rather than from durable core profitability. For a bank whose NIM has printed 0.8-0.9% across ten consecutive quarters, sustaining a premium-to-tangible-book multiple would typically require ROTCE in the high single digits or better, and the reported figures do not yet demonstrate this. Investors should monitor whether the multiple compresses toward the peer median if the earnings recovery stalls.
Leverage Carries a Sub-Scale Return Profile
Amerant's 2.9% quarterly ROE in 2026Q3 derives mostly from roughly 12.5x asset leverage (0.08 equity/assets) rather than earning power, as a 0.3% ROA over ten quarters averaging near 0.15% shows, according to Amerant's reported ratios, meaning returns are thin before any credit or funding shock.
The DuPont decomposition points to asset productivity, not capital structure, as the binding constraint: with fee income contributing only 16.9% of revenue in 2026Q3, profitability remains overwhelmingly dependent on spread income that NIM data suggests is structurally compressed. The elevated leverage cuts both ways — it amplifies the modest ROA into a passable ROE today, but it also means any single-quarter credit event, such as the $6.2 million provision in 2026Q3, lands on a comparatively thin equity base of $840.8 million.
Flat Margin and Distorted Cost Ratio
NIM has been trapped between 0.8% and 0.9% for ten straight quarters while net interest income fell 3.9% year over year to $90.5 million in 2026Q3, per Amerant's income statements, and the 63.5% efficiency ratio, though the best in the series, follows quarters of 144.5% and 2.4% that render trend comparisons unreliable.
A NIM that barely moves regardless of rate conditions suggests Amerant's asset yields and deposit costs reprice in tandem, consistent with a balance sheet dominated by securities rather than a differentiated, sticky funding advantage that should produce margin insulation. The efficiency ratio's improvement to 63.5% is directionally encouraging given management's stated cost discipline, but three of the ten quarters in the series are distorted by revenue-base anomalies, so the underlying operating leverage remains unproven rather than confirmed.
Equity Cushion at Cycle Low
Equity declined to $840.8 million in 2026Q3 from $914.4 million a quarter earlier, pulling the equity-to-assets ratio to 0.08, its weakest reading since 2024Q2 against a $10.2 billion balance sheet, based on Amerant's reported figures, leaving limited visible room to absorb losses or sustain buybacks.
While regulatory CET1 and Tier 1 ratios are not disclosed in the supplied data and therefore cannot be assessed directly, the book-equity trajectory — compounded by an apparent $18.7 million buyback in 2026Q1 that appears reversed in 2026Q2 — suggests capital return has been episodic rather than programmatic. The 0.9% dividend yield is modest, which may indicate management is preserving capital, but with equity/assets at a cycle low and securities at roughly 89% of assets exposing book value to mark-to-market swings, the capacity for discretionary capital action appears constrained.
Premium Multiple Without Premium Returns
Against the supplied peer set, Amerant's 1.32x P/B exceeds OCFC (0.57x), BUSE (1.10x), and SFNC (0.92x) and trails only IBCP (1.54x), yet its ROE of 2.9% sits below BUSE's 9.5% and far below IBCP's 14.1%, per peer comparison data, a disconnect that frames the multiple as expectation-driven.
The valuation gap versus Seacoast-style peers appears to reflect the market's pricing of Amerant's specialized South Florida deposit franchise rather than demonstrated returns, since the ROE differential suggests the funding advantage has not yet converted into superior profitability. Notably, the peer group spans very different risk profiles — SFNC's negative ROE and P/E make it an outlier, and OCFC's 5.1% yield reflects a low-multiple, capital-return model — so the structural question for Amerant is whether its multiple premium persists if ROE fails to converge toward the 8-10% range peers at similar multiples typically generate.
P/E Misreads Provision-Driven Earnings
The most commonly misapplied ratio here is the 23.86x trailing P/E, which compares price against earnings distorted by a $48.3 million reserve release in 2026Q2 followed by a $6.2 million charge in 2026Q3, per Amerant's reported provisions, making the multiple oscillate between expensive and cheap for purely accounting-driven reasons.
Provision swings of this magnitude mean reported net income — and therefore P/E — reflects management's reserve modeling at least as much as franchise earnings power, so an investor anchoring on trailing P/E could misjudge both the quality and the sustainability of the current earnings level. A more defensible frame is P/TBV of roughly 1.41x evaluated against pre-provision, pre-tax revenue trends and the flat sub-1% NIM, since tangible book value is far less sensitive to quarterly reserve decisions; the forward P/E of 13.69x should also be treated skeptically, as it implicitly assumes reserve normalization and cost efficiency gains that the historical ratio series does not yet confirm.